These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25298126)

  • 1. Biomarkers in the diagnosis of ADHD--promising directions.
    Faraone SV; Bonvicini C; Scassellati C
    Curr Psychiatry Rep; 2014 Nov; 16(11):497. PubMed ID: 25298126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4).
    Gizer IR; Waldman ID
    J Abnorm Psychol; 2012 Nov; 121(4):1011-23. PubMed ID: 22564179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of DAT1 and COMT variants on neural activation during response inhibition in adolescents with attention-deficit/hyperactivity disorder and healthy controls.
    van Rooij D; Hoekstra PJ; Bralten J; Hakobjan M; Oosterlaan J; Franke B; Rommelse N; Buitelaar JK; Hartman CA
    Psychol Med; 2015 Nov; 45(15):3159-70. PubMed ID: 26073896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study.
    Payton A; Holmes J; Barrett JH; Hever T; Fitzpatrick H; Trumper AL; Harrington R; McGuffin P; O'Donovan M; Owen M; Ollier W; Worthington J; Thapar A
    Am J Med Genet; 2001 Jul; 105(5):464-70. PubMed ID: 11449400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder.
    Hong SB; Zalesky A; Park S; Yang YH; Park MH; Kim B; Song IC; Sohn CH; Shin MS; Kim BN; Cho SC; Kim JW
    Hum Brain Mapp; 2015 Jan; 36(1):367-77. PubMed ID: 25201318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies.
    Kebir O; Joober R
    Eur Arch Psychiatry Clin Neurosci; 2011 Dec; 261(8):583-94. PubMed ID: 21409419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children.
    Tahir E; Yazgan Y; Cirakoglu B; Ozbay F; Waldman I; Asherson PJ
    Mol Psychiatry; 2000 Jul; 5(4):396-404. PubMed ID: 10889550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic background of ADHD: population studies, genes of the catecholamine system].
    Słopién A; Dmitrzak-Weglarz M; Rybakowski F; Rajewski A; Hauser J
    Psychiatr Pol; 2006; 40(1):19-31. PubMed ID: 16756025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
    Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic bases of attention deficit hyperactivity disorder].
    Sanchez-Mora C; Ribases M; Mulas F; Soutullo C; Sans A; Pamias M; Casas M; Ramos-Quiroga JA
    Rev Neurol; 2012 Nov; 55(10):609-18. PubMed ID: 23143962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
    Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder.
    Caylak E
    Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):613-27. PubMed ID: 22825876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?
    Gold MS; Blum K; Oscar-Berman M; Braverman ER
    Postgrad Med; 2014 Jan; 126(1):153-77. PubMed ID: 24393762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.
    Swanson JM; Kinsbourne M; Nigg J; Lanphear B; Stefanatos GA; Volkow N; Taylor E; Casey BJ; Castellanos FX; Wadhwa PD
    Neuropsychol Rev; 2007 Mar; 17(1):39-59. PubMed ID: 17318414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.